Most published ashwagandha trials tested 250-600 mg of standardized root extract daily for 8-12 weeks and reported mostly mild side effects like nausea or an upset stomach; newer 2026 data extends that picture to higher doses and a full year of use, while a small number of liver-injury case reports mean the supplement still isn’t right for everyone.
Ashwagandha has spent the last few years as one of the most talked-about adaptogens on the supplement shelf, usually framed around stress and cortisol. Less attention goes to the more practical questions: how much is actually being tested in trials, how long is safe to take it, and who should sit this one out. A run of newer clinical work, including a large randomized trial and a 12-month observational study, gives a clearer answer than the marketing copy on most bottles.
This guide sticks to that lane; it doesn’t revisit whether ashwagandha actually lowers cortisol or eases stress (we’ve covered that question in a separate article on this site). What follows is dosing ranges from real trials, how long those trials ran, what the adverse-event data shows, and who should avoid ashwagandha or talk to a doctor before starting.
What the New Clinical Data Actually Shows
Ashwagandha (Withania somnifera) research has historically leaned on short trials with small samples, which made safety conclusions shaky. That’s shifted: several studies published through 2026 add larger sample sizes and longer follow-up, painting a fairly consistent picture.
Standard-dose trials
A large randomized, double-blind, placebo-controlled study of roughly 1,000 participants evaluated 600 mg per day of a standardized KSM-66 root extract over eight weeks. Researchers tracked liver enzymes, kidney markers, and blood counts, and reported no clinically meaningful shifts and no serious adverse events. It’s one of the largest controlled safety datasets on a single ashwagandha extract to date, and it lines up with smaller trials in the 250-600 mg range that found similar tolerability.
Higher-dose tolerability
A separate 12-week trial pushed the dose to around 2,000 mg per day, and still found it generally well tolerated; over 85% of participants had no adverse events at all, and liver, kidney, and thyroid markers stayed within normal ranges on average. A dose that performed well in one controlled trial isn’t automatically appropriate for unsupervised daily use outside the extract and population studied, though.
Longer-duration data
The more useful addition may be duration. A prospective, multi-center observational study followed close to 200 healthy adults taking 600 mg of standardized extract daily for a full year, logging 18 mild adverse events total (mostly nausea, some abdominal discomfort, occasional headache), none serious enough to require stopping. Liver, kidney, and thyroid function again showed no concerning trend over the 12 months, meaningfully more long-term reassurance than the field had two or three years ago, when most safety data topped out around 8-12 weeks.
The liver signal that still matters
None of this erases a smaller body of evidence: documented case reports of liver injury associated with ashwagandha use, generally at doses of 450-1,350 mg per day, taken anywhere from about a week to four months, with injury typically surfacing two to twelve weeks after starting and often following a cholestatic pattern (affected bile flow, sometimes jaundice). Standardized extracts like KSM-66 and Sensoril used in the controlled trials above haven’t shown this signal, but not every product on shelves matches the exact formulation tested in a trial, and individual reactions can happen even with a generally well-tolerated ingredient.
How to Think About Dosing in Practice
Translating trial data into a real-world routine takes judgment, since trials use standardized, tested extracts under supervision, and store shelves don’t.
Typical clinically-tested ranges
Most of the safety and efficacy literature clusters around 300-600 mg per day of a root extract standardized to withanolide content (commonly 5%), split into one or two doses, and that range is generally treated in the clinical literature as a reasonable starting point. Going meaningfully higher, into four-figure territory, has only been tested in a limited number of trials, so it’s not something to self-escalate toward without a healthcare provider’s input.
Extract type matters more than the milligram number
“600 mg of ashwagandha” isn’t a single, interchangeable thing. KSM-66 and Sensoril are trademarked, standardized root extracts (from Ixoreal Biomed and Natreon, respectively) that show up repeatedly in the clinical literature because their withanolide content is controlled and consistent between batches. A generic “ashwagandha root powder” capsule at the same milligram count may contain a different concentration of active compounds, part of why trial results don’t automatically transfer to every bottle on a shelf. As an illustration of format, not a product recommendation, a typical KSM-66-based capsule from a brand like Nutricost or Gaia Herbs is formulated in the 300-600 mg range that mirrors what’s actually been studied.
Duration and cycling
The 12-month data is reassuring for continuous use at standard doses, but most controlled trials still top out around 8-12 weeks. A conservative approach some clinicians suggest is periodic breaks (a few weeks off after two to three months of use) rather than open-ended daily use with no reassessment.
Common Misconceptions About Ashwagandha Safety
- “Natural means it can’t hurt you.” Ashwagandha is pharmacologically active, which is exactly why it may support stress-related outcomes in some studies. Compounds active enough to help can also interact with medications or affect lab values, true of most herbal supplements.
- “More milligrams is automatically better.” The 2,000 mg trial showed the extract was generally tolerated at a higher dose, not that higher doses outperform the more commonly studied 300-600 mg range.
- “Any supplement labeled ashwagandha matches what was in the study.” Standardized extract percentage and sourcing vary by brand and batch; a label claim doesn’t guarantee it matches the exact extract tested in a given trial.
- “Liver risk means everyone should avoid it.” The documented case reports are real but appear uncommon relative to how widely the supplement is used, and the largest recent controlled trials didn’t reproduce the signal. It’s a reason for informed caution, particularly with existing liver risk factors, not a blanket verdict.
- “It’s non-sedating, so it’s fine with sleep medication or alcohol.” Ashwagandha has calming, sedative-adjacent effects on its own, and combining it with other CNS depressants may compound drowsiness.
Who Should Avoid Ashwagandha, or Check With a Doctor First
This section is the core of the guide, not an afterthought. None of the following is a complete medical eligibility check; it’s a starting point for a conversation with a healthcare provider who knows your history.
Pregnancy and breastfeeding
Ashwagandha has traditionally been associated with uterine-stimulating effects, and there isn’t reliable safety data in pregnant or breastfeeding populations. Clinical guidance is generally to avoid it during pregnancy and while nursing unless a physician who knows the full picture advises otherwise.
Thyroid conditions
Some research has observed increases in thyroid hormone levels (particularly T4) in people with subclinical hypothyroidism who took standard doses. That’s a real concern for anyone with hyperthyroidism, Graves’ disease, or who is already on thyroid medication, where an added hormonal push isn’t wanted. Anyone with a diagnosed thyroid condition should loop in their prescribing doctor before starting.
Autoimmune conditions
Ashwagandha may have immune-stimulating properties in some research, framed as a potential general-wellness benefit but a caution flag for autoimmune conditions such as lupus, rheumatoid arthritis, multiple sclerosis, or Hashimoto’s thyroiditis, where stimulating immune activity is exactly what treatment usually tries to avoid.
Upcoming surgery
Between possible central-nervous-system and immune-modulating effects, several clinical sources recommend stopping ashwagandha at least two weeks before a scheduled surgery to avoid unpredictable interactions with anesthesia or wound healing.
Liver conditions or liver-affecting medications
Given the documented, if uncommon, case reports of liver injury, anyone with existing liver disease, elevated liver enzymes, or who takes other liver-processed medications should talk to a doctor before adding ashwagandha, and consider periodic liver-function monitoring if they do.
Medication interactions to flag with a pharmacist or doctor
- Sedatives and CNS depressants (benzodiazepines, sleep medications, alcohol): may compound drowsiness.
- Thyroid medication: potential for additive effects on thyroid hormone levels, as noted above.
- Immunosuppressants: possible immune-stimulating activity may work against drugs meant to dampen immune response (common after transplants or for autoimmune treatment).
- Diabetes medication: some research suggests ashwagandha may lower blood sugar, which could compound insulin or oral diabetes drugs.
- Blood pressure medication: may have a mild blood-pressure-lowering effect in some studies, worth factoring in for anyone on antihypertensives.
Tools and Products That Can Help
If you and your doctor land on trying a standardized extract, look for one that names the specific extract (KSM-66 or Sensoril, for example) and its withanolide percentage rather than a generic “ashwagandha root powder,” since that’s the format the clinical trials above actually used.
Ashwagandha is also frequently paired with other daily supplement categories. If focus is part of what you’re after alongside stress support, our best nootropics for focus roundup covers formulas built around that goal. Some multivitamin lines aimed at women now build in adaptogen blends; our best women’s multivitamins guide breaks down which ones do that well. And for anyone who prefers adaptogens as part of a daily greens routine, our best greens powders roundup flags which formulas include ashwagandha or similar ingredients.
FAQ
What’s a typical safe starting dose of ashwagandha?
Most clinical trials use 300-600 mg per day of a standardized root extract (commonly 5% withanolides), split into one or two doses. That range is where the bulk of the safety and tolerability data sits.
How long is it safe to take ashwagandha daily?
A 12-month observational study found standard doses generally well tolerated over a full year, though most controlled trials only ran 8-12 weeks. Some clinicians suggest periodic breaks rather than indefinite continuous use, especially without lab monitoring.
Can ashwagandha damage your liver?
A small number of documented case reports describe liver injury associated with ashwagandha use, typically at doses of 450-1,350 mg per day. Large recent controlled trials using standardized extracts haven’t reproduced that signal, but anyone with existing liver risk factors should talk to a doctor first.
Is ashwagandha safe during pregnancy?
General clinical guidance is to avoid ashwagandha during pregnancy and while breastfeeding, given traditional associations with uterine-stimulating effects and a lack of reliable safety data in these populations.
Does ashwagandha interact with thyroid medication?
It may. Some research shows ashwagandha can raise thyroid hormone levels, a caution for anyone on thyroid medication or with hyperthyroidism, and worth discussing with a prescribing doctor.
Bottom Line
The newest clinical data on ashwagandha is more reassuring than what existed a couple of years ago: standardized extracts at 300-600 mg per day have now been studied in larger groups and, in one case, over a full year, with mostly mild side effects. Higher doses have also shown reasonable tolerability in shorter trials. None of that erases the smaller set of liver-injury case reports or the real interaction risks for people who are pregnant, have thyroid or autoimmune conditions, or take certain medications. The dosing question and the “who should avoid it” question are really the same question: this is a supplement worth bringing to a doctor before starting, not just adding to a routine because a trial made headlines.